Basilea PharmaceuticaBSLN 
$45.70-0.48%24h
-0.48%24h
Global rank10773
Market cap$548.03M
Change 7d0.98%
YTD Performance-
SP500 benchmark
P/E53.14
P/S3.13
Revenue$175.07M
Earnings$11.61M
Dividend yield-
Market capitalization of Basilea Pharmaceutica (BSLN)
As of January 2025, Basilea Pharmaceutica has a market cap of $548.03M. This makes Basilea Pharmaceutica the world's 10773th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Basilea Pharmaceutica from 2004 to 2024
-
Value:-
Market cap history of Basilea Pharmaceutica from 2004 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $498.09M | 5.95% |
| 2023 | $470.12M | -22.93% |
| 2022 | $609.96M | 11.93% |
| 2021 | $544.97M | -23.01% |
| 2020 | $707.84M | 13.42% |
| 2019 | $624.07M | 17.27% |
| 2018 | $532.18M | -47.35% |
| 2017 | $1.01B | 3.83% |
| 2016 | $973.53M | -24.09% |
| 2015 | $1.28B | 4.50% |
| 2014 | $1.23B | -12.57% |
| 2013 | $1.40B | 136.32% |
| 2012 | $593.98M | 24.93% |
| 2011 | $475.45M | -45.08% |
| 2010 | $865.66M | 0.85% |
| 2009 | $858.34M | -56.72% |
| 2008 | $1.98B | -32.47% |
| 2007 | $2.94B | 4.24% |
| 2006 | $2.82B | 53.24% |
| 2005 | $1.84B | 53.59% |
| 2004 | $1.20B | - |
BSLN Market Cap Today is $548.03M -0.48% - 11 Jan 2025
View largest stocks by market cap 
